Cita APA

Takigawa, N., Ochi, N., Nakagawa, N., Nagasaki, Y., Taoka, M., Ichiyama, N., . . . Yamane, H. (2020). Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors? Cancers (Basel).

Citación estilo Chicago

Takigawa, Nagio, et al. "Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit From Immune Checkpoint Inhibitors?" Cancers (Basel) 2020.

Cita MLA

Takigawa, Nagio, et al. "Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit From Immune Checkpoint Inhibitors?" Cancers (Basel) 2020.